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Transmembrane (TM) peptides often induce toxic effects when expressed in bacteria, probably due to membrane destabilization. We
report here that in the case of the TM domains of hepatitis C virus (HCV) E1 and E2 envelope proteins, which are both particularly toxic for
the bacteria, the insertion of the Asp-Pro (DP) sequence dramatically reduced their toxicities and promoted their expressions when produced
as glutathione S-transferase (GST) GST-DP-TM chimeras. Subcellular fractionation showed that these chimeras co-sediment with the
membrane fraction and contain active GST that could be solubilized with a mild detergent. Surprisingly, immuno-gold electron microscopy
clearly showed that such chimeras are not localized in the membrane but in the cytosol. We thus postulate that they likely form proteo-lipidic
aggregates, which prevent the bacteria from toxicity by sequestering the TM part of the chimeras. The reduction of toxicity in the presence of
the Asp-Pro sequence is possibly due to Asp’s negative charge that probably disadvantages the binding of the TM peptides to the membrane.
In addition, the structural features of Pro residue could promote the formation of chimera aggregates.
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Membrane proteins represent about 30% of all proteins to
be encoded by genomes [1,2]. There is growing interest in
these proteins due to their wide spectrum of structural and
functional roles, such as solute transport [3], signal trans-
duction and communication between compartments, but
also viral envelope assembly or membrane fusion. Their
membrane localization is ensured by the presence of one or
more hydrophobic stretches of 20–25 residues [4,5], which
are generally folded in a-helices [4–6] but in some cases in
h-sheets [7,8]. Structural information contained within these
transmembrane (TM) segments in terms of three-dimension-
al structure, orientation, shape and packing is critical for
further understanding of their function. However, the deter-
mination of their structure by crystallography or NMR
remains a bottleneck due to the difficulties encountered in
producing large amounts of membrane peptides and proteins
[9,10].
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produced by chemical synthesis, though their hydrophobic
nature makes their successful synthesis uncertain in terms
of purity and yield. This is mainly due to the propensity of
hydrophobic peptides to aggregate and the difficulties
encountered in maintaining their solubility. Their purifica-
tion by conventional means (e.g. RP-HPLC) is problematic
as they tend to interact irreversibly with the stationary
phase of chromatographic columns [11]. The addition of
charged, preferentially basic residues to the hydrophobic
peptide ends has been described to reduce these effects (cf.
Melnyk et al. [12] and references therein). For longer
hydrophobic peptides, chemical synthesis remains possible,
but only in a limited number of cases [13]. NMR is
generally used for three-dimensional structure determina-
tion of short membrane domains [14], but this often
requires uniform 15N and/or 13C labeling which is very
expensive due to the price of labeled amino acids. A
cheaper alternative is the overproduction of these peptidesFig. 1. HCV polyprotein processing, and amino acid sequences of E1 and E2 enve
study. Schematic representation of the HCV polyprotein. After translation, proce
generates core protein (C) and the envelope proteins E1 and E2. Arrows indicate th
the generated proteins (numbered according to the positions of amino acid residu
domains of E1 and E2 are symbolized by a tandem of open and closed rectangle
including p7 and NS3 to NS5B proteins. The amino acid sequences of E1 and E
residues) correspond to those expressed in this work. The numbers indicated at seq
genotype 1a; EMBL access number: #D00831 and #M67463 for TME1 and TME2
present work are displayed. Residues belonging to the expression plasmid are in i
detailed.in bacteria using 15N and/or 13C labeled growth medium.
However, membrane proteins often induce toxic effects
which can lead to the death of the microorganism [15,16],
possibly due to membrane destabilization and leakage or
pore formation. Different systems have been developed for
optimizing the expression of membrane proteins, either by
modifying the strain [15,17], or reducing toxicity by the
insertion of a leader peptide [18], or by controlling their
expression [19,20]. When produced, hydrophobic peptides
may accumulate in the membrane fraction or in the form
of inclusion bodies, which can then be further purified. A
better understanding of recombinant membrane peptide
expression in bacteria would be helpful in overcoming
their toxicity.
Hepatitis C virus (HCV) is a major cause of liver
diseases such as cirrhosis and hepatocellular carcinoma.
This virus contains a 9500-base-long positively stranded
RNA [21] which encodes for a single polyprotein at the
level of the ER membrane. This polyprotein is furtherlope glycoprotein TM domains and GST chimeras expressed in the present
ssing of the N-terminal region of the polyprotein by ER signal peptidase
e cleavage sites and the numbers indicate the first N-terminal amino acid of
es in the HCV polyprotein of genotype 1a, strain H). Ectodomain and TM
s, respectively. The dotted rectangle symbolizes the rest of the polyprotein
2 C-terminal regions containing their respective TM domains (underlined
uence edges correspond to the position of residues in the polyprotein (HCV
, respectively). Sequences of the proteins and GST chimeras expressed in the
talics. Sequence of GSTkt is indicated in a box and its C-terminal region is
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proteins (for a review, see Ref. [22]). Among these, the two
glycoproteins E1 and E2 are responsible for viral envelope
formation. Processing of these proteins is achieved by
signal peptidase cleavage in the endoplasmic reticulum
(ER) lumen (Fig. 1). E1 and E2 are type I TM proteins
with N-terminal ectodomains of about 160 and 360 amino
acids, respectively, and a short C-terminal TM domain of
approximately 30 amino acids (Fig. 1). Both E1 and E2
TM domains are formed by two stretches of hydrophobic
amino acids separated by a short polar segment containing
fully conserved charged residues [23]. After signal pepti-
dase cleavage, each TM domain forms a single TM helix as
a result of a dynamic process of C-terminal stretch reori-
entation [24,25]. E1 and E2 TM domains are involved
during different steps of virus formation, acting as translo-
cation re-initiation signals for the downstream coded pro-
teins and promoting E1–E2 heterodimer formation [26].
They are also probably involved in fusion complex forma-
tion for virus cell entry. Structural analysis of both E1 and
E2 TM domains is thus essential to provide a framework
for the molecular understanding of these mechanisms and
which could permit the identification of novel targets for
antiviral intervention. However, the expression of full-
length E1 and E2 proteins or their domains using eukary-
otic heterologous expression systems [27] yields insuffi-
cient amounts of protein for structural investigations.
Attempts at producing the full-length E1 protein in E. coli
or in sf9 insect cells using the baculovirus system [28–30]
have had limited success, due to the toxicity associated
with expression of the protein, or more precisely that of its
C-terminal hydrophobic domain. No attempts to express E2
in bacteria have so far been reported.
In this report, we describe that the expression of the TM
domains of HCV E1 (TME1) and E2 (TME2) in E. coli,
either alone or fused with glutathione S-transferase (GST),
was not possible due to very high associated toxicity.
Surprisingly, however, the insertion of an Asp-Pro se-
quence between the GST and TME1 or TME2, added for
chemical cleavage purposes, reduced TME1 and TME2
toxicity and promoted their overexpression as GST chime-
ras. Cell fractionation experiments showed that a signifi-
cant amount of the GST chimeras sedimented with the
membrane fraction in an active GST form that could be
further solubilized with a mild detergent. At the ultrastruc-
tural level, however, these chimeras were immuno-local-
ized only in the cytosol. These data suggest the existence
of micellar-like aggregates and proteo-lipidic aggregates
that prevent the membrane peptide to reach the membrane
and consequently confer protection against toxicity. The
reduction in toxicity due to the presence of an Asp-Pro
sequence is tentatively attributed to the negative charge on
the Asp residue that probably reduces the propensity of
TM domains binding to the membrane and/or to the
promotion of micellar forms of aggregates possibly facil-
itated by the presence of Pro residues.2. Experimental procedures
2.1. Materials
Oligonucleotides were synthesized by EUROBIO. The
Qiaprep kit for DNA plasmid preparation was from QIA-
GEN. The BigDyek Terminator Cycle ABI PRISMR for
DNA sequencing was from Applied Biosystems. E. coli
BL21(DE3) and BL21(DE3)[pLysS] strains were purchased
from Stratagene. The C41 and C43 [15] (BL21(DE3)) E.
coli strains were kindly provided by Dr. Bruno Miroux
(Faculte´ de Me´decine Necker-Enfants-Malades, CNRS-
UPR 9078, 156 rue de Vaugirard, 75730 PARIS CEDEX
15). DNA restriction and modification enzymes were from
New England Biolabs. Precision protein standards, Kalei-
doscope prestained standards, miniprotean 3 and its trans-
blot module, GS-700 and Molecular Analyst were from Bio-
Rad. The pCRRT7 topo TA plasmid was from Invitrogen.
The Vibracell 72408 was from Fisher Bioblock Scientific.
The pET32a+ plasmid was from Novagen. K38 E. coli
strain, pT7-7 and pGP1-2 plasmids [31] were kindly pro-
vided by Prof S. Tabor (Department of Biological Chemis-
try, Harvard Medical school, Boston, Mass, USA). The
pGEXKT plasmid [32] was kindly provided by Prof. Dixon
(Department of Biological Chemistry, University of Mich-
igan Medical School, Ann Arbor, USA). Bacterial culture
products were from Difco Laboratories and N-dodecyl-h-D-
maltoside (DM) was from Anatrace Inc. Immobilon-P
membranes were from Millipore and the Anti-GST antibody
GST(Z-5):sc-459 was from Santa Cruz Biotechnology, Inc.
The ECL kit was from Amersham Biosciences and gold
particles conjugated to anti-rabbit IgG were from British
Biocell. LR white resin was from Electron Microscopy
Sciences. Other products were purchased from Sigma-
Aldrich Corp.
2.2. Strains
Epicurian ColiR BL21(DE3): E. Coli B F dcm ompT
hsdS(rB
mB
 ) gal E(DE3), Epicurian ColiR BL21(DE3)
[pLysS]: E. coli BL21(DE3)[pLysS Camr]. E. coli K38
(HfrC E) is described by Tabor [31]. C41 and C43 E. coli
strains were obtained from BL21(DE3) and described by
Miroux and Walker [15].
2.3. Plasmid constructs
Genes encoding the E1 and E2 TM domains (TME1 and
TME2) were generated de novo by polymerase chain
reaction (PCR) [33] using optimized codons for E. coli
expression [34]. Subcloning for the different plasmids was
done using a set of two long and two short oligonucleotides
as displayed in Table 1. The corresponding TME1 and
TME2 amino acid sequences are shown in Fig. 1. All
constructions were optimized by using vector NTI 6.0
software.
Table 1
Oligonucleotides used to generate and clone TME1 and TME2 coding sequences
TME1 gene synthesis and cloning:
Synthesis OL11(+) 5V-atgccatatg__ atcgctggtgctcactggggtgttctggctggtatcgcttacttctctatggttggtaactggg
OL12( ) 5V-gcatatcgatctaagcgtcaacaccagcgaacagcagcagaacaaccagaactttagcccagttaccaaccatagagaa
Without DP sequence: With DP sequence:
Sub-cloning OL13(+) 5V-gggaatgccatatgatcgctggtg OL113(+) 5V-gaattcctaagcgtcaacaccagc
in pT7-7 OL14( ) 5V-gcatatcgatctaagcgtcaaca OL114( ) 5V-cgcatatggacccgatcgctggtgct
Sub-cloning OL15(+) 5V-ggatccatggaatacgttgttc OL17(+) 5V-ggatccgacccgatggaatacgttgttc
OL16( ) 5V-gaattcctaagcttcagcctgag OL16( )
TME2 gene synthesis and cloning:
Synthesis OL21(+) 5V-catatg__ gaatacgttgttctgctgttcctgctgctggctgacgctcgtgtttgctcttgcctgtggat
OL22( ) 5V-aagcttaagcttcagcctgagagatcagcagcatcatccacaggcaagagcaaacac
Without DP sequence: With DP sequence:
Sub-cloning OL23(+) 5V-catatggaatacgttgttc OL213(+) 5V-cagaattcctaagcttcagcctgagag
in pT7-7 OL24( ) 5V-aagcttaagcttcagcctgagagatcag OL214( ) 5V-cgcatatggacccggaatacgttgttc
Sub-cloning OL25(+) 5V-ggatccgaatacgttgttc OL27(+) 5V-ggatccgacccggaatacgttgttc
in pGEXKT OL26( ) 5V-gaattcttaagcttcagcctgagagatcag OL26( )
Constructions and designs of the oligonucleotides were carried out with vector NTI 6.0 and Oligo 5.0 softwares. Starting codon ATG is underlined twice.
Underlined bases correspond to the hybridizing region between each couple of long oligonucleotides. Restriction sites are in italics.
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sequence was achieved by generating PCR fragments from
each synthetic DNAwith OL13 and OL14 primers for TME1
and OL23 and OL24 primers for TME2 (Table 1). Fragments
were subcloned into the pCRRT7 topo TA plasmid, then
extracted using NdeI and ClaI restriction enzymes for TME1
and NdeI and HindIII restriction enzymes for TME2, and
finally cloned into pT7-7 using the same sites to yield
plasmids pT7-7-TME1 and pT7-7-TME2.
Cloning into pGEXKT [35], in frame with the 3V end
of the gene coding for GSTkt and with or without the
sequence encoding the Asp-Pro, was achieved by gener-
ating PCR fragments from each synthetic DNA with OL15
(DP) or OL17 ( +DP) and OL16 (TME1) and OL25
(DP) or OL27 ( + DP) and OL26 (TME2) primers
(Table 1). Fragments were subcloned into the pCRRT7
topo TA plasmid and then cloned into pGEXKT using
BamHI and EcoRI restriction enzymes to yield plasmids
pGEXKT-TME1, pGEXKT-TME2, pGEXKT-DPTME1 and
pGEXKT-DPTME2.
Cloning into pT7-7 [31] with the insertion of the DP
sequence was achieved by generating PCR fragments from
plasmids pGEXKT-DPTME1 and pGEXKT-DPTME2 with
OL113 and OL114 primers for TME1 and OL213 and
OL214 primers for TME2 (Table 1). Fragments were cloned
into pT7-7 using NdeI and EcoRI restriction enzymes to give
plasmids pT7-7-DPTME1 and pT7-7-DPTME2. All the pro-
duced proteins are summarized in Fig. 1.
2.4. Expression tests
Expression with pT7-7 constructs was carried out as
described [31] after transformation of K38[pGP1-2],BL21(DE3) or BL21(DE3)[pLysS] bacteria. When possible,
about 10 clones were picked from plates and tested for
expression. Bacteria were diluted in 5 ml of Luria Bertani
culture medium (LB) supplemented with ampicillin (and
kanamycin for K38[pGP1-2]), then grown until saturation at
37 jC and 200 rpm. Cultures were then diluted 1/10 in the
same medium and grown for 1 h before induction, either by
increasing the temperature to 42 jC for 15 min for the K38
strain, or by adding 1 mM isopropyl-1-thio-h-D-galactoside
(IPTG) for the BL21(DE3)-type strains. Expression was
continued for 3–6 h at 37 jC and growth of each culture
was followed by periodic checking of the OD600 nm. After a
3-h expression, a volume equivalent to 0.1 OD600 nm was
withdrawn and pelleted. The pellet was suspended in 50-
Al water then 50-Al lysis buffer (see Section 2.8), followed
by mixing and heating for 1 min at 100 jC before analyzing
10 Al by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE).
2.5. Expression at low temperature
Bacteria transformed with pGEXKT, pGEXKT-DPTME1
or pGEXKT-DPTME2 were grown in LB medium contain-
ing 50 Ag/ml ampicillin, at 37 jC and 200 rpm, until a cell
density of 2.0 OD600 nm/ml was reached. The cultures were
then cooled on ice to quickly decrease the temperature to 20
jC and then incubated for at least 30 min at 20 jC before to
induce them by adding 0.5 mM IPTG. Expression was
carried out overnight (15–17 h) at 20 jC and 200 rpm.
Cell density was estimated (f 5–6 OD600 nm/ml) and
bacteria were harvested by centrifugation at 5000 gav
(6750 rpm) in a JA10 Beckman rotor (J2-MC Beckman
centrifuge), for 15 min at 4 jC. Bacteria were washed in the
C. Montigny et al. / Biochimica et Biopsame volume of cold water and centrifuged again. The pellet
was suspended in buffer A (25 mM Tris–Cl pH 7.0, 5 mM
MgCl2, 5 mM h-mercaptoethanol, 1 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride (PMSF)) to a final density of
f 100 OD600 nm/ml and either stored on ice for immediate
use or frozen in liquid N2 and stored at  80 jC.
2.6. Cellular fractionation
Each bacterial suspension was poured into a 50-ml
beaker and cells were disrupted with a Vibracell 72408
sonifier equipped with a 10-mm-diameter probe. Sonication
was carried out for 1 min by ON/OFF pulses of 0.5 s and by
setting the generator to 30% of maximal power. The
suspension was maintained below 10 jC with ice. Disrup-
tion was continued until there was a 10-fold decrease in cell
density, which generally took about 7 min. An aliquot of the
suspension was withdrawn (‘‘bacteria’’ in Fig. 4A), and
unbroken material and inclusion bodies were discarded by
centrifugation at 5000 gav (6750 rpm) in a JA10 Beckman
rotor (J2-MC Beckman centrifuge), for 15 min. The super-
natant (referred to as ‘‘bacterial extract’’, Fig. 4) was
centrifuged at 100,000 gav (36,000 rpm) in a Ti45 Beck-
man rotor (L8-M Beckman centrifuge), for 120 min at 10
jC. The membrane-rich pellet is referred to as the ‘‘mem-
branous fraction’’, and the supernatant that contained the
soluble material is referred to as the ‘‘soluble fraction’’ (see
Fig. 4). The pellet (‘‘membranous fraction’’) was suspended
in 5–6 ml of buffer B (20 mM Tris–Cl pH 7.0, 300 mM
sucrose, 5 mM h-mercaptoethanol, 1 mM EDTA), then
frozen in liquid nitrogen and stored at  80 jC.
2.7. Solubilization of membrane proteins
Solubilization of the ‘‘membranous fraction’’ was per-
formed using 2-mg protein aliquots diluted in a final volume
of 1-ml buffer B with the addition of 6-mg h-D-dodecyl
maltoside/30 Al (DM/protein ratio = 3). Solubilization was
carried out for 30 min at 20 jC, followed by centrifugation
at 10 jC for 30 min at 100,000 gav (50,000 rpm) with a
TLA100 rotor in a TL100 Beckman centrifuge.
2.8. Protein electrophoresis
Aliquots of 20 Al containing 0.1- to 120-Ag protein were
mixed with an equal volume of lysis buffer containing 100
mM Tris–Cl pH 8.0, 1.4 M h-mercaptoethanol, 140 mM
SDS, 5 mM EDTA, 8 M Urea and 0.72 mM bromophenol
blue [36]. Samples were heated at 100 jC for 1 min, cooled
and then loaded, either on 14% polyacrylamide gels pre-
pared and treated as described, either by Laemmli [37] for
protein of MW higher than 10 kDa (SDS-PAGE), or on
16.5% tricine-polyacrylamide gels as described by Schagger
and von Jagow [38], to separate peptides (tricine-PAGE).
Electrophoresis was carried out with a Bio-Rad miniprotean
3 device.2.9. Protein estimation
Protein concentrations were measured by the bicincho-
ninic acid procedure [39] in the presence of 17 mM SDS.
2.10. Western blotting
After SDS-PAGE, gels were incubated for 5 min in cold
CAPS buffer (10 mM CAPS-NaOH pH 11.1, 10% MeOH)
and proteins were blotted onto Immobilon-P membranes
with a Bio-Rad Protein 3 transblot module for 90 min at 150
V and 250 mA, in cold CAPS buffer. Blotting membranes
were incubated for 30 min in 20 ml of PBST buffer (90 mM
K2HPO4, 10 mM KH2PO4, pH 7.7, 100 mM NaCl, 0.2%
Tween-20 (polyoxyethylenesorbitan monolaurate), contain-
ing 10% dry fatty acid-free milk. GST(Z-5):sc-459 poly-
clonal antibody ( +HRP) was added to a 1/2000 dilution for
1 h. Blots were then washed three times for 10 min in 20 ml
of PBST buffer and bands detected by chemoluminescence,
using the ECL kit.
2.11. GST activity measurements
GST activity was measured spectrophometrically accord-
ing to the procedure published by Habig et al. [40].
Measurements were carried out in 2-ml 100 mM KH2PO4
pH 6.5, 1 mM GSH, in a cuvette thermostated at 25 jC with
stirring. As substrate, 1 mM of 1-chloro-2,4-dinitrobenzene
was added and the reaction was started by the addition of 5
Al of sample and recorded at 340 nm for 300 s. Slopes were
corrected for the value obtained with the control assay
carried out without enzyme.
2.12. Immuno-electron microscopy
Bacterial pellets were fixed in 2.5% paraformaldehyde in
0.15 M cacodylate buffer pH 7.4, rinsed in buffer alone and
then dehydrated in graded ethanol solutions. Sample prepa-
rations were done as detailed previously [41,42]. Briefly,
progressive infiltration with the LR white acrylic resin and
embedding was performed according to the manufacturer’s
instructions. Polymerization was induced by incubation at 56
jC for 24 h. Silver to gold sections were mounted on formvar-
coated nickel grids. Before immunolabeling, sections were
hydrated in phosphate-buffered saline (PBS) and saturated in
1% BSA diluted in PBS. Grids were then floated for 1 h on
drops containing the primary antibody against GST (diluted
1/50 in PBS-BSA), rinsed, and incubated with 10-nm gold
particles conjugated with anti-rabbit IgG (British BioCell,
Cardiff, UK) diluted 1/30 in PBS-BSA for 45 min. After
extensive washing in PBS, samples were fixed with 2%
glutaraldehyde, rinsed with water and dried. Sections were
contrasted in methanolic uranyl acetate and lead citrate.
Observations were performed with a Philips CM120 trans-
mission electronmicroscope at the Centre de Technologie des
Microstructures, Claude Bernard University, Lyon, France.
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3.1. Choice of limits of TME1 and TME2 domains
Since E1 and E2 envelope glycoproteins are synthesized
in series in the HCV polyprotein, between the Core and P7
proteins (Fig. 1), the C-terminal ends of TME1 and TME2
are generated by signal peptidase cleavage during process-
ing, at amino acids 384 and 747, respectively. Their N-
terminal ends are less precisely known, but according to
previous work [27], we have chosen to start them at residues
348 for TME1 and 717 (positions on the polyprotein) for
TME2. The sequences of TME1 and TME2, shown in Fig.
1, correspond to those expressed in this work. In order to
optimize the biosynthesis of these small domains of 36 and
31 residues for TME1 and TME2, respectively, the coding
genes were generated by PCR using E. coli preferred codons
(see Section 2).
3.2. Expression of TME1 or TME2 is highly toxic for E. coli
To test the expression of TME1 and TME2 alone, we
first tried the system developed by Tabor [31] based on a
T7 promoter and thermal induction as described in the
original procedure (see Section 2). The first unusual
feature was that the yield of transformation of the
K38[pGP1-2] E. coli strain with the expression plasmids
pT7-7-TME1 or pT7-7-TME2 was very low. In addition,
transformed strains did not produce detectable amounts of
peptides, at least at the Coomassie-staining level, as judged
by electrophoresis carried out with tricine-PAGE [38] (not
shown).
The same constructs were used to transform BL21(DE3)
and BL21(DE3)[pLysS] strains in which the gene coding for
the T7 RNA polymerase was integrated in the bacterial
genome and induced by IPTG (see Section 2). The same
transformation difficulties were observed for the BL21(DE3)
strain. In contrast, it was possible to get transformed
BL21(DE3)[pLysS] clones for which the small amount of
T7 lyzozyme expressed by the pLysS plasmid efficiently
repressed traces of T7 RNA polymerase expressed without
induction. However, as shown in Fig. 2A, positive clones
containing pT7-7-TME1 or pT7-7-TME2 stopped growing
just after the addition of IPTG. No specific protein expres-
sion was observed on tricine-PAGE stained with Coomassie
blue (Fig. 2B), whatever clones were tested. As indicated in
Section 2, the expression experiments were carried out at 37
jC. Since reducing the temperature is known to promote the
expression of membrane proteins [9,43], we also tried to
reduce the temperature during the expression step, but this
led neither to expression of the peptides nor reduction of the
toxicity (not shown). These results demonstrate that the
small amounts of TME1 or TME2 expressed at the very
beginning of the induction were sufficient to kill the bacteria.
This can also explain why the selection of clones from the
K38[pGP1-2] or BL21(DE3) strains was so difficult. Indeed,expression in these strains is not as tightly controlled as that
bearing pLysS.
3.3. The expression of TME1 and TME2 as GSTkt chimeras
reduces their toxicity for E. coli
The expression of TME1 and TME2 fused to the C-
terminus of GST was tested using the pGEXKT plasmid
designed by Hakes and Dixon [32]. This plasmid contains a
sequence coding for a linker of five glycine residues
followed by the thrombin site at the C-terminus of GST.
The GST protein expressed in the pGEXKT plasmid corre-
sponds to GST-GGGGGLVPRGSPGIHRD and is referred
to below as GSTkt. GSTkt-TME1 corresponds to the
sequence GST-GGGGGLVPRGS-TME1, and GSTkt-
TME2 corresponds to GST-GGGGGLVPRGS-TME2. Ami-
no acid sequences of both chimeras are detailed in Fig. 1.
Neither T7 RNA polymerase nor pLysS was necessary to
test the expression of the GSTkt chimeras since pGEXKT
carries the gene coding for GSTkt under the control of an
IPTG-inducible promoter. Nevertheless, the BL21(DE3)
[pLysS] E. coli strain was used for comparison purposes
with the expression of TME1 and TME2 alone. It was
possible to select positive clones after transformation and to
test them for expression. When compared to the growth
curve obtained for pT7-7 constructs (Fig. 2A), the induction
of GSTkt-TME1 and GSTkt-TME2 expression by IPTG
resulted in reduced toxicity, as shown in Fig. 2C. However,
among about 20 clones tested for each construct, none
expressed GSTkt-TME1 in detectable amounts and only
one expressed a limited amount of the GSTkt-TME2 chi-
mera (Fig. 2D). The latter was only produced in the form of
inclusion bodies and all attempts at solubilization and
refolding of GST failed (not shown), thereby preventing
recovery of TME2 by thrombin cleavage.
We also carried out a series of experiments in which
expression of chimeras was tested in the C41 and C43
BL21(DE3)-type E. coli strains isolated by Miroux and
Walker [15] and found to be resistant to the toxicity induced
by the expression of membrane proteins. Unfortunately, no
expression was obtained with these strains, whatever the
temperature. In addition, it was possible to isolate several
resistant strains, but none of them expressed the chimeras.
3.4. Insertion of an Asp-Pro sequence between GST and
TME1 or TME2 dramatically reduces the toxicity of TM
domains and promotes GST chimera production
As described above, TME2 could not be cleaved from
GSTkt-TME2 inclusion bodies by thrombin. An Asp-Pro
sequence (DP) was thus introduced upstream to TME2 in the
construct (see sequence in Fig. 1) to allow its release from
GST by acidic chemical cleavage. The Asp-Pro bond is well
known to be specifically cleaved in the presence of formic
acid (70%) or diluted HCl (10 mM) [44], i.e., under con-
ditions that do not require the native state of the GSTchimera.
Fig. 2. Expression of TME1 and TME2 alone or in fusion with GSTkt in the presence or absence of the Asp-Pro sequence at the fusion junction. (Panels A, C,
E) Growth curves of E. coli BL21(DE3)[pLysS] strain transformed with pT7-7 (A) or pGEXKT (C, E) expression vectors, either alone (circles) or coding for
TME1 (squares) or TME2 (diamonds). When indicated, the Asp-Pro sequence (DP) was present at the junction between GSTkt and TME1 or TME2 (E).
Clones were grown at 37 jC in liquid medium up to saturation. After dilution to a density of about 0.5 OD600nm/ml in the same medium, expression was
triggered after 1 h by the addition of IPTG as indicated. Cell density was followed as a function of time. (Panels B, D, F) SDS-PAGE analysis of bacterial
proteins expressed after a 3-h induction with the different constructs. (B) Proteins expressed with the pT7-7 series; SDS-PAGE using a 16.5% polyacrylamide
tricine gel (see Section 2). Lanes ‘‘myo’’ and ‘‘lmw’’ correspond to peptides from the Sigma ‘‘myo’’ kit and protein low weight markers from Amersham
Biosciences, respectively. The corresponding molecular weights are indicated on the left and the right, respectively. (D and F) Proteins expressed in the
pGEXTKT series with (F) or without (D) the Asp-Pro sequence inserted. SDS-PAGE using a 14% polyacrylamide Laemmli gel (see Section 2). GSTkt
chimeras are indicated by arrows. The gel displayed in (F) was run over a longer period to improve the separation of the GSTkt chimeras.
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[pLysS] strain with the GSTkt-DP-TME2 chimera, expres-
sion was much less toxic for the host than that of the
GSTkt-TME2 chimera without the Asp-Pro sequence (com-
pare open diamond growth curves in Fig. 2E and C,
respectively). Furthermore, this reduced toxicity was related
to an increase in the production of the GSTkt-DP-TME2
chimera (Fig. 2F) when compared to GSTkt-TME2 produc-
tion (Fig. 2D).
Introduction of the Asp-Pro sequence at the junction
between GSTkt and TME1 (see Fig. 1) produced a
similar effect. Expression of the GSTkt-DP-TME1 chi-
mera was less toxic for the bacteria than GSTkt-TME1
(compare open square growth curves in Fig. 2E and C,
respectively). Of particular interest is the fact that all the
clones tested expressed the GSTkt-DP-TME1 chimera
(Fig. 2E), while essentially no expression was detected
for GSTkt-TME1 (Fig. 2D). As expected, both GST-DP-
TM chimeras could be proteolyzed with acid formic,
even when expressed as inclusion bodies (data not
shown).3.5. Insertion of the Asp-Pro sequence upstream of TME1
or TME2 expressed alone decreases the toxicity of TM
domains
As insertion of the Asp-Pro sequence reduced TME1
and TME2 toxicity expressed in GSTkt chimeras, we
tested whether this could also be efficient when inserted
upstream of the TM domains expressed alone. The
corresponding plasmids were generated from the pGEXKT
constructs (as detailed in Section 2 and shown in Fig. 1)
and BL21(DE3)[pLysS] competent strains were trans-
formed and checked for growth before and after IPTG
induction (Fig. 3). The resulting strains remained sensitive
to the expression of either DP-TME1 (panel A, open
squares) or DP-TME2 (panel B, open diamonds) upon
IPTG induction, since they grew slower than the strain
transformed with the empty plasmid (open circles). These
strains appeared thus less sensitive to TME1 or TME2
toxicity when compared to those transformed with the
plasmids expressing these TM domains alone (closed
symbols). However, whatever the temperature used, ex-
Fig. 3. Toxicity reduction of TM domain expression by insertion of the
Asp-Pro sequence into pT7-7 vectors expressing TME1 or TME2 alone.
Growth curves of E. coli strain BL21(DE3)[pLysS] transformed either with
the empty vector pT7-7 or coding for TME1 or TME2 peptides, cloned
alone or preceded by a DP coding sequence. Growth conditions, IPTG
induction, and recording were as described in the legend to Fig. 2. Error
bars were calculated from the data of three different experiments for each
construct.
Fig. 4. Subcellular localization and GST activity of GSTkt-DP-TME1 and
GSTkt-DP-TME2 chimeras by cellular fractionation. (A) Immunodetection
of GST in various subcellular fractions of bacteria expressing GSTkt (G),
GSTkt-DP-TME1 (GT1), and GSTkt-DP-TME2 (GT2) chimeras. Bacteria
were grown at 37 jC and then cooled to 20 jC before induction and
overnight expression at 20 jC, as described under Section 2. Subcellular
fractionation was performed as detailed under Section 2. Bacteria were
suspended, sonicated, and then submitted to low-speed centrifugation to
yield the ‘‘bacterial extract’’ fraction. This fraction was submitted to high-
speed centrifugation to give the ‘‘soluble fraction’’ and the ‘‘membranous
fraction’’. For each fraction, protein were separated on a 12% SDS-PAGE
and blotted onto Immobilon-P membranes before immunodetection of the
GST moiety. (B) Activity of GST in the various subcellular fractions. The
‘‘solubilized membranous fraction’’ was obtained by solubilization of the
‘‘membranous fraction’’ with DM and then centrifuged to discard the non-
solubilizable fraction. GST activity was measured as detailed under Section
2. GST activity of each expressed chimera is indicated as the percent of the
activity measured in the ‘‘bacterial extract’’ fraction, which was fixed at
100%. Depending of the fraction and the chimera, the summation of the
soluble and membranous fractions does not exactly correspond to 100%,
probably due to a partial activation or inhibition of the GST in the presence
of detergent.
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they could not be detected on a Coomassie blue-stained
SDS-PAGE (not shown). Nevertheless, these data demon-
strate that the addition of an Asp-Pro sequence alone
contributes to lowering the toxicity induced by membrane
domain expression.
3.6. Cellular localization of expressed GSTkt-DP-TME1
and GSTkt-DP-TME2
To better understand the reduction in TME1 and TME2
associated toxicity when expressed in fusion with the GST-
DP sequence, we explored the cellular localization of the
GSTkt-DP-TME1 and GSTkt-DP-TME2 chimeras. When
protein expression was carried out at 37 jC, the chimeras
accumulated mainly in the form of inclusion bodies (data
not shown). These conditions are useful to produce large
amount of chimeras but did not permitted detailed local-
ization of chimeras in the cell by immuno-electron mi-croscopy (see below). To reduce the level of inclusion
bodies, the temperature of expression was reduced to 20
jC and induction time increased to 15–17 h. In addition,
these conditions are commonly used to promote the
folding of expressed proteins [9]. After expression, bacteria
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separated by differential centrifugation followed by analy-
sis by SDS-PAGE and Western blotting, using an antibody
raised against the GST moiety (Fig. 4A). As illustrated in
the ‘‘bacteria’’ panel, the GSTkt-DP-TME2 chimera was
produced at about the same level as GSTkt alone. For
unknown reasons, the band obtained with this chimera was
always ‘‘fuzzy’’, as observed also in the Coomassie blue-
stained gel (see Fig. 2F). This is possibly related to the
presence of two cysteine residues in TME2. Indeed,
mutations of Cys726 and Cys728 to Ala yielded a well-
focused band for the corresponding GST-DP-TME2 mutant
(data not shown). The GSTkt-DP-TME1 chimera could
also be produced in reasonable amounts but two bands of
about the same intensity were always observed in the
‘‘bacteria’’ fraction (Fig. 4A), despite the presence of
PMSF and EDTA during sonication. The band of higher
molecular weight is expected to be full-length GST-DP-
TME1 while the lower band migrating at about the level of
GST is likely an abortive chimera or a proteolytic product
containing only a part of TME1.
Initial low-speed centrifugation released cell debris and
inclusion bodies and about 2/3 of the proteins were recov-Fig. 5. Subcellular localization of GSTkt-DP-TME1 and GSTkt-DP-TME2 chime
the legend to Fig. 4 and then processed for immunolabeling as described under Se
ultrathin sections were successively exposed to rabbit anti-GST polyclonal antibo
strain; (B, C, and D) bacterial strains expressing GSTkt, GSTkt-DP-TME1 and Gered in the supernatant named ‘‘bacterial extract’’ (Fig. 4A).
Both GSTkt and GSTkt-DP-TME2 chimeras were largely
recovered in this fraction. In contrast, GSTkt-DP-TME1
could only be partially recovered, indicating that a large part
of this chimera was still produced in the form of inclusion
bodies. As illustrated in the ‘‘bacterial extract’’ and ‘‘bacte-
ria’’ panels, the GSTkt-DP-TME2 chimera exhibited a
tendency to form oligomers. This is probably partially due
to the oxidation of cysteine residues present in TME2
despite the presence of h-mercaptoethanol during the frac-
tionation process and SDS-PAGE analysis. Indeed, the
amount of GSTkt-DP-TME2 oligomer was significantly
lowered when the Cys residues were mutated to Ala (data
not shown).
High-speed centrifugation of the ‘‘bacterial extract’’
fraction allowed the separation of ‘‘soluble’’ proteins from
the ‘‘membranous fraction’’. As shown in Fig. 4A, the
GSTkt chimera was found mainly in the ‘‘soluble fraction’’
while both GSTkt-DP-TME1 and GSTkt-DP-TME2 chime-
ras sedimented mainly with proteins of the ‘‘membranous
fraction’’. Some oligomeric forms of both GSTkt-DP-TME1
and GSTkt-DP-TME2 could be observed in the latter
fraction.ras by immuno-electron microscopy. Bacteria were induced as described in
ction 2. After fixing and embedding the bacterial pellets in LR white resin,
dy and 10-nm gold particles conjugated with anti-rabbit IgG. (A) Control
STkt-DP-TME2, respectively. Bar = 200 nm.
Fig. 6. Possible behavior of overexpressed TM domains fused to GST in
bacteria. As the hydrophobic TM peptide is fused at the C-terminus of GST
(symbolized as a globule), it is thought to be synthesized unfolded in the
cytosol (symbolized as an extended chain). GST-TM chimeras could
associate together by their hydrophobic TM peptides to form inclusion
bodies (left, thin arrow). However, the presence of full-length GST-TM
chimeras in the ‘‘soluble fraction’’ suggests the presence of some ‘‘micellar-
like aggregate’’ (middle left, thin arrow) similar to the so-called ‘‘soluble
inclusion bodies’’ described by Nomine et al. [45]. In such types of
aggregate, the hydrophobic TM peptides are probably buried whereas the
GST moieties are exposed to the cytosol. It is possible that some lipids
associated with TM peptides could be present in both inclusion bodies and
micellar-like aggregates. In such case, these lipids could allow the folding
of TM peptides in a-helices. Because of its hydrophobic nature, the TM
peptide could drive the binding and insertion of chimera to the bacterial
membrane (right, dotted arrow), and fold into an alpha helix (symbolized as
a helix). This pathway is probably toxic for the bacteria, due to membrane
destabilization. Alternatively, the TM peptide could form ‘‘proteo-lipidic
aggregates’’ (middle right, thick closed arrow) by association with lipids
(indicated in gray) (see text for further explanation). Nevertheless and
whatever the formation pathway, the various aggregates probably neutralize
the toxicity of TM peptides by keeping them away from the bacterial
membranes. Hence, any means of avoiding the targeting of hydrophobic
TM peptides to bacterial membrane should result in reducing their toxicity.
This could be achieved by the addition of an Asp-Pro sequence upstream of
the TM sequences (see main text).
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to transfer glutathione to 1-chloro-2,4-dinitrobenzene as
described in Section 2. As shown in Fig. 4B, glutathione
transferase activity was detected in the ‘‘bacterial extract’’ as
well as in the ‘‘membranous fraction’’ containing GSTkt-
DP-TME1 or GSTkt-DP-TME2 chimeras, indicating that
the GST moiety in each chimera was functional, and thus
well folded, despite its fusion with a hydrophobic mem-
brane peptide. As expected for a soluble protein, GST
activity associated with GSTkt was essentially found in
the ‘‘soluble fraction’’ and not in the ‘‘membranous frac-
tion’’. In contrast, some GST activity was found for GSTkt-
DP-TME1 and GSTkt-DP-TME2 chimeras in the ‘‘soluble
fraction’’, despite the presence of hydrophobic membrane
peptide moiety. In the case of GSTkt-DP-TME1, the most
abundant protein corresponds to the low molecular weight
band supposed to be an abortive or proteolytic product of
GST-DP-TME1 (see above). This product is likely respon-
sible of the rather high GST activity observed in the
corresponding ‘‘soluble fraction’’. In contrast, very limited
amounts of abortive or proteolytic product are observed for
GSTkt-DP-TME2 in the corresponding fractions. However,
the presence of limited amount of full-length GSTkt-DP-
TME1 and GSTkt-DP-TME2 chimeras in the ‘‘soluble
fraction’’ suggests the existence of some soluble ‘‘micel-
lar-like aggregates’’ small enough to remain in solution after
centrifugation (see Section 4 below). Interestingly, solubili-
zation of the ‘‘membranous fraction’’ by the mild detergent
DM, followed by high-speed centrifugation, recovered all
the GST activity in the ‘‘solubilized fraction’’ for both
GSTkt-DP-TME1 and GSTkt-DP-TME2 chimeras (Fig.
4B). These results strongly suggest the presence of lipids
associated with GSTkt-DP-TME1 and GSTkt-DP-TME2
chimeras since mild detergents as DM are not efficient to
solubilize aggregated proteins or inclusion bodies. This
constitutes a clear indication that the GST moiety is asso-
ciated via TME1 or TME2 to some membranous structure.
Moreover, the GST moiety of both GSTkt-DP-TME1 and
GSTkt-DP-TME2, solubilized by DM and purified by
affinity on GSH-agarose, was efficiently cleaved by throm-
bin (see Supplementary Material). This is in keeping with
the native state of GST in both chimeras and constitutes a
direct proof of the thrombin site accessibility provided by
the design of our constructs.
3.7. GSTkt-DP-TME1 or GSTkt-DP-TME2 chimeras are
clustered in the cytosol of E. coli
The above fractionation experiments suggest that the
GSTkt-DP-TME1 and GSTkt-DP-TME2 chimeras could
be associated with the bacterial membrane. To determine
the subcellular localization of these chimeras, immuno-
electron microscopy of sections of bacteria expressing the
chimeras was carried out. Fig. 5 shows the immuno-gold
electron microscopic detection of the GST moiety of GSTkt-
DP-TME1 and GSTkt-DP-TME2 chimeras in thecorresponding strain (panels C and D, respectively) com-
pared to a strain expressing GSTkt alone (panel B) and a
control strain (panel A). In all cases, the GST chimeras were
detected in electron-dense regions with a homogeneous
texture corresponding to the cytosolic compartment, but only
exceptionally detected in or close to the membrane region, as
in GSTkt (panel B). In addition, the gold particles were often
found stacked together, forming clusters of varying size. All
these data indicate that GSTkt-DP-TME1 and GSTkt-DP-
TME2 chimeras are not associated with the bacterial mem-
brane. Moreover, the presence of GST clusters related to the
presence of lipids associated with GSTkt-DP-TME1 and
GSTkt-DP-TME2 leads us to suppose that these chimeras
form ‘‘proteo-lipidic aggregates’’ as tentatively represented
in Fig. 6.
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The present work highlights an original property of the
Asp-Pro sequence which contributes to a reduction in the
strong toxicity associated with the expression of HCV E1
and E2 TM domains in bacteria and which promotes the
production of GST-TM chimeras. This toxicity is thought to
be due to the integration of TME1 and TME2 into the
membrane, causing sufficient structural and/or functional
disorders to kill the bacteria. The presence of an Asp-Pro
sequence upstream of TME1 or TME2 is not sufficient by
itself to promote the expression of these domains in appre-
ciable amounts. Moving from the pT7-7 plasmid to the
pGEXKT plasmid actually contributed to some reduction of
the TM domains toxicity. This effect can be due to the
presence of GST encoded by pGEXKT plasmid but also to
the different promotion systems of respective plasmids.
Indeed, it is known that T7 and tac promoters, present in
pT7-7 and pGEXKT, respectively, can be critical for
expressing membrane proteins in bacteria [9]. The Asp-
Pro effect is more clearly evident when the dipeptide is
inserted between the GST and TME1 or TME2 fusion
proteins. Indeed, high levels of the corresponding chimeras
(GSTkt-DP-TME1 and GSTkt-DP-TME2) could be pro-
duced in E. coli, while no or low expression was observed
for GSTkt-TME1 and GSTkt-TME2 chimeras, respectively.
To better understand the reduced toxicity of TME1 and
TME2 towards bacteria when expressed fused to a GST-DP
sequence, we explored the cellular localization of the
chimera by subcellular fractionation and immuno-gold
electron microscopy. These experiments allowed us to
propose a general scheme for the behavior of expressed
TM domains when fused to GST in bacteria (Fig. 6).
According to this scheme, when released from the ribo-
some, GST chimeras mainly aggregate in the cytosol in the
form of inclusion bodies probably due to the stacking of
their C-terminal membrane domains (Fig. 6, left). The
presence of some full-length GSTkt-DP-TME1 and
GSTkt-DP-TME2 chimeras in the soluble fraction suggests
that parts of the chimeras could be organized as ‘‘micellar-
like aggregates’’ (Fig. 6, middle left). These soluble aggre-
gates are thought to be similar to the so-called ‘‘soluble
inclusion bodies’’ that have been described by Nomine et
al. [45] for the HPV E6 oncoprotein fused to maltose-
binding protein. It is not clear whether these inclusion
bodies and/or micellar-like aggregates contain lipids. In
addition, the folding status of the TM peptides in these
aggregates is not known. It is clear, however, that the
retention of the TM peptides into these aggregates yields
complexes that are non-toxic to the bacteria, though the
formation of these aggregates does not explain the presence
of active GST chimeras associated with lipids in the
membranous subcellular fraction. Because of their hydro-
phobic nature, TM sequences located at the C-terminus of
GST chimeras could behave as membrane insertion sequen-
ces and anchor the chimeras in the bacterial membrane, asobserved for the so-called tail-anchored membrane proteins
[46]. However, this pathway is likely to be toxic to the
bacteria due to membrane destabilization. Furthermore, this
pathway is not supported by our immuno-electron micros-
copy results since the GST chimeras were not detected in
the membrane region of the bacteria but in the cytosolic
compartment where they seem to form clusters. Taken
together, these results suggest that the GST-TM chimeras
probably form ‘‘proteo-lipidic aggregates’’ by association
with cellular lipids. The structure of these aggregates is
tentatively represented in Fig. 6 (middle right). Such
aggregates could exhibit a similar density to that of the
E. coli membrane, thus explaining their presence in the
‘‘membranous fraction’’. A key feature of these aggregates
that distinguishes them from inclusion bodies is the pres-
ence of active GST in expressed chimera that can be
solubilized with a mild detergent. Moreover, the GST
moiety of both GSTkt-DP-TME1 and GSTkt-DP-TME2
was efficiently cleaved by thrombin. This finding opens
new perspectives for the preparation of membrane peptides
using such chimeras. This is also in keeping with the
proposal that both TM peptides associated to the ‘‘pro-
teo-lipidic aggregates’’ are in a ‘‘native’’ state. Indeed, the
presence of lipids likely permits the folding of TM peptides
into their native state, i.e., a-helices, which offer the most
thermodynamically favored conformation in a membrane
environment. Such folding is supported by our recent NMR
structure analysis, which demonstrated that the N-terminal
hydrophobic stretch of E1 forms an a-helix in a membrane
environment [27]. Moreover, preliminary structural analy-
ses of chemically synthesized peptides corresponding to
TME1 and TME2 clearly indicate that both domains adopt
an a-helical fold in any membrane mimetic environments
tested (data not shown). These proteo-lipidic aggregates
thus open interesting new perspectives for the structural
and functional study of exogenous membrane domains
expressed in bacteria. The formation and structure of these
proteo-lipidic aggregates remain elusive but they are effec-
tive in neutralizing the potential toxicity of TM peptides by
keeping them away from the bacterial membrane. Howev-
er, one cannot exclude that GST-DP-TM chimeras initially
insert into the membrane and then somehow bud off as
proteo-lipidic aggregates.
The above results suggest that the addition of the Asp-
Pro sequence upstream from TME1 or TME2 reduces their
toxic effects by altering their binding to the bacterial
membrane. This tendency is enhanced when a soluble
protein such as GST is fused upstream of the construct.
From the present work, it is not possible to have a clear-cut
answer about the respective role of aspartic or proline
residues or both for reducing the toxicity of TM peptides.
However, the charge residue seems to have a critical
importance. Indeed, Campion et al. [47] have shown that
introducing negatively charges residues between phospha-
tase alkaline and human heregulin/human epidermal growth
factor hybrids increased the level of expression of these
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toxic than TME1 contains an acidic residue at its N-
terminal end (Glu 717) while TME1 has a basic residue,
His 352, at the same position. Although molecular mech-
anisms of peptide binding to the membrane remain poorly
understood, it is generally observed that positively charged
residues promote the binding of membrane peptide to the
membrane through electrostatic interactions with negatively
charged phospholipids [48,49]. On the contrary, negatively
charged residues tend to decrease membrane binding due to
electrostatic repulsion effect. Consequently, the additional
negative charge born by the Asp-Pro sequence might
prevent TME1 and TME2 peptides from binding to the
membrane. The proline residue should have a more limited
role since such a residue is already present at the C-
terminal end of the GST while the corresponding chimeras
remain toxic without DP. It is, however, not excluded that
the particular structural features of the proline residue
inserted with the Asp-Pro sequence favor the formation
of stable chimera aggregates.
In conclusion, our results clearly indicate that the mod-
ification of the physico-chemical properties of the N-termi-
nus of toxic membrane peptides could efficiently overcome
their toxicity and permit their expression in bacteria. Re-
markably, insertion of an Asp-Pro sequence upstream of a
membrane peptide appears to be a useful method for
preventing the toxicity of expressed membrane peptides
by promoting their aggregation in the cytosol, and increas-
ing their production. The properties of the Asp-Pro sequence
could therefore be critical for successful expression of other
toxic hydrophobic domains of membrane proteins in E. coli
and should therefore contribute to increasing the number of
structural and functional studies of these proteins.Acknowledgements
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